[
    [
        {
            "time": "2018-07-24",
            "original_text": "7月24日A股龙虎榜揭秘，机构最青睐10股",
            "features": {
                "keywords": [
                    "龙虎榜",
                    "机构",
                    "青睐",
                    "医药"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "7月24日A股龙虎榜揭秘，机构最青睐10股",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-07-25",
            "original_text": "三天10%，百亿资金狂补基建，七翻身有望？",
            "features": {
                "keywords": [
                    "基建",
                    "资金",
                    "补仓",
                    "七翻身"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "基建"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "三天10%，百亿资金狂补基建，七翻身有望？",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-07-26",
            "original_text": "四机构席位卖出智飞生物5.93亿元",
            "features": {
                "keywords": [
                    "智飞生物",
                    "机构",
                    "卖出"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "四机构席位卖出智飞生物5.93亿元",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-07-27",
            "original_text": "机构博弈医药股，长生生物获小幅买入",
            "features": {
                "keywords": [
                    "机构",
                    "博弈",
                    "长生生物",
                    "买入"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "机构博弈医药股，长生生物获小幅买入",
                "Correlation": 7,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-07-28",
            "original_text": "医药生物行业点评：2018Q2公募基金医药持仓比重和集中度提升",
            "features": {
                "keywords": [
                    "医药生物",
                    "公募基金",
                    "持仓",
                    "提升"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药生物行业点评：2018Q2公募基金医药持仓比重和集中度提升",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-07-29",
            "original_text": "[互动]智飞生物：制定严格质量安全机制等确保疫苗产品安全有效",
            "features": {
                "keywords": [
                    "智飞生物",
                    "质量安全",
                    "疫苗",
                    "安全有效"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "[互动]智飞生物：制定严格质量安全机制等确保疫苗产品安全有效",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-07-30",
            "original_text": "智飞生物被巨资撬开跌停，“错杀”医药股获机构青睐抢筹大战上演！",
            "features": {
                "keywords": [
                    "智飞生物",
                    "巨资",
                    "跌停",
                    "机构",
                    "青睐"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物被巨资撬开跌停，“错杀”医药股获机构青睐抢筹大战上演！",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-07-31",
            "original_text": "长生生物造假基金狂砍估值惨烈 疫苗股股权质押风险火烧连营",
            "features": {
                "keywords": [
                    "长生生物",
                    "造假",
                    "基金",
                    "估值",
                    "疫苗股",
                    "股权质押"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "长生生物造假基金狂砍估值惨烈 疫苗股股权质押风险火烧连营",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 10,
                "Impact": 10,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        }
    ]
]